retatrutide phase 2 obesity trial results Retatrutide approval: FDA status, clinical trial results, and when it could be available VisualAbstract: Retatrutide reduces body weight

Kelly, C.M., Juurlink, D.N., Gomes, T., Duong-Hua, M., Pritchard, K.I., Austin, P.C

Expert Formulated: Developed by top industry experts and third-party tested for purity and potency

Many patients report that after a few months on BioTE, they feel like themselves again, only better: stronger, leaner, sharper, and more emotionally resilient

IGF-1 vs IGF-1 LR3: Native Signal vs Extended Anabolic Window Insulin-like Growth Factor 1 (IGF-1) and its long-acting analog IGF-1 LR3 share the same receptor but differ radically in duration of action, and that difference drives almost every clinical decision between them

PMCID: PMC5820209